Corvus hawaiiensis isolate bCorHaw1 chromosome 19, bCorHaw1.pri.cur, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Corvoidea; Corvidae; Corvus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036364.1.\nAssembly name: bCorHaw1.pri.cur\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGSY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2021\nAssembly Method :: HiFiasm v. 0.15.4+galaxy; purge_dups v.\n 1.2.5+galaxy3; Bionano Solve v.\n 3.6.1+galaxy2; Salsa v. 2.3+galaxy0;\n gEVAL manual curation v. 2021-09-20; VGP\n pipeline v. 2.0\nAssembly Name :: bCorHaw1.pri.cur\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 29.61x\nSequencing Technology :: PacBio Sequel II HiFi; Illumina NovaSeq;\n Bionano Genomics Saphyr DLS; Arima\n Genomics Hi-C v2\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Corvus hawaiiensis Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
casein kinase 1 delta, transcript variant X5
casein kinase 1 delta, transcript variant X1
casein kinase 1 delta, transcript variant X2
casein kinase 1 delta, transcript variant X4
casein kinase 1 delta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
solute carrier family 16 member 3, transcript variant X1
solute carrier family 16 member 3, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: coiled-coil domain-containing protein 57
dihydrouridine synthase 1 like, transcript variant X2
dihydrouridine synthase 1 like, transcript variant X1
tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like isoform X1
tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like isoform X2
G protein pathway suppressor 1, transcript variant X1
G protein pathway suppressor 1, transcript variant X2
COP9 signalosome complex subunit 1 isoform X1
COP9 signalosome complex subunit 1 isoform X2
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
beta-1,3-N-acetylglucosaminyltransferase radical fringe
dicarbonyl and L-xylulose reductase, transcript variant X1
dicarbonyl and L-xylulose reductase, transcript variant X2
Rac family small GTPase 3, transcript variant X3
Rac family small GTPase 3, transcript variant X1
Rac family small GTPase 3, transcript variant X2
ras-related C3 botulinum toxin substrate 3 isoform X1
ras-related C3 botulinum toxin substrate 3 isoform X3
ras-related C3 botulinum toxin substrate 3 isoform X2
leucine rich repeat containing 45, transcript variant X4
leucine rich repeat containing 45, transcript variant X3
leucine rich repeat containing 45, transcript variant X2
leucine rich repeat containing 45, transcript variant X1
leucine-rich repeat-containing protein 45 isoform X4
leucine-rich repeat-containing protein 45 isoform X3
leucine-rich repeat-containing protein 45 isoform X2
leucine-rich repeat-containing protein 45 isoform X1
centromere protein X, transcript variant X2
centromere protein X, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X2
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X1
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X3
tether containing UBX domain for GLUT4 isoform X2
tether containing UBX domain for GLUT4 isoform X1
tether containing UBX domain for GLUT4 isoform X3
notum, palmitoleoyl-protein carboxylesterase
palmitoleoyl-protein carboxylesterase NOTUM
myeloid associated differentiation marker like 2
myeloid-associated differentiation marker-like protein 2
pyrroline-5-carboxylate reductase 1, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: NAD-dependent protein deacetylase sirtuin-7
phosphate cytidylyltransferase 2, ethanolamine, transcript variant X1
phosphate cytidylyltransferase 2, ethanolamine, transcript variant X2
ethanolamine-phosphate cytidylyltransferase isoform X1
ethanolamine-phosphate cytidylyltransferase isoform X2
anaphase promoting complex subunit 11, transcript variant X2
anaphase promoting complex subunit 11, transcript variant X1
anaphase-promoting complex subunit 11 isoform X1
anaphase-promoting complex subunit 11 isoform X2
Rho GDP dissociation inhibitor alpha, transcript variant X1
Rho GDP dissociation inhibitor alpha, transcript variant X2
Rho GDP dissociation inhibitor alpha, transcript variant X3
protein phosphatase 1 regulatory subunit 27, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 27 isoform X2
protein phosphatase 1 regulatory subunit 27, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 27 isoform X1
MAPK regulated corepressor interacting protein 1
mapk-regulated corepressor-interacting protein 1
glucagon receptor, transcript variant X1
glucagon receptor, transcript variant X2
glucagon receptor, transcript variant X4
glucagon receptor, transcript variant X3
39S ribosomal protein L12, mitochondrial
hepatocyte growth factor-regulated tyrosine kinase substrate, transcript variant X2
hepatocyte growth factor-regulated tyrosine kinase substrate, transcript variant X1
hepatocyte growth factor-regulated tyrosine kinase substrate isoform X2
hepatocyte growth factor-regulated tyrosine kinase substrate isoform X1
transmembrane channel like 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transmembrane channel like 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transmembrane channel like 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transmembrane channel like 6, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transmembrane channel like 6, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transmembrane channel like 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane channel-like protein 6 isoform X2
transmembrane channel-like protein 6 isoform X1
probable low-specificity L-threonine aldolase 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: probable low-specificity L-threonine aldolase 2
CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial
ubiquitin specific peptidase 36, transcript variant X2
ubiquitin specific peptidase 36, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 36 isoform X2
ubiquitin carboxyl-terminal hydrolase 36 isoform X1
calcium activated nucleotidase 1, transcript variant X2
calcium activated nucleotidase 1, transcript variant X1
soluble calcium-activated nucleotidase 1 isoform X1
soluble calcium-activated nucleotidase 1 isoform X2
C1q and TNF related 1, transcript variant X2
C1q and TNF related 1, transcript variant X1
complement C1q tumor necrosis factor-related protein 1
cytosolic endo-beta-N-acetylglucosaminidase
RNA binding fox-1 homolog 3, transcript variant X6
RNA binding fox-1 homolog 3, transcript variant X9
RNA binding fox-1 homolog 3, transcript variant X12
RNA binding fox-1 homolog 3, transcript variant X15
RNA binding fox-1 homolog 3, transcript variant X13
RNA binding fox-1 homolog 3, transcript variant X14
RNA binding fox-1 homolog 3, transcript variant X11
RNA binding fox-1 homolog 3, transcript variant X1
RNA binding fox-1 homolog 3, transcript variant X8
RNA binding fox-1 homolog 3, transcript variant X10
RNA binding fox-1 homolog 3, transcript variant X4
RNA binding fox-1 homolog 3, transcript variant X3
RNA binding fox-1 homolog 3, transcript variant X2
RNA binding fox-1 homolog 3, transcript variant X5
RNA binding fox-1 homolog 3, transcript variant X7
RNA binding protein fox-1 homolog 3 isoform X3
RNA binding protein fox-1 homolog 3 isoform X2
RNA binding protein fox-1 homolog 3 isoform X5
RNA binding protein fox-1 homolog 3 isoform X1
RNA binding protein fox-1 homolog 3 isoform X4
RNA binding protein fox-1 homolog 3 isoform X6
uncharacterized LOC125335864, transcript variant X2
uncharacterized LOC125335864, transcript variant X1
ectonucleotide pyrophosphatase/phosphodiesterase 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
ectonucleotide pyrophosphatase/phosphodiesterase family member 7
TBC1 domain family member 16, transcript variant X4
TBC1 domain family member 16, transcript variant X7
TBC1 domain family member 16, transcript variant X6
TBC1 domain family member 16, transcript variant X1
TBC1 domain family member 16, transcript variant X2
TBC1 domain family member 16, transcript variant X3
TBC1 domain family member 16, transcript variant X5
coiled-coil domain containing 40, transcript variant X4
coiled-coil domain containing 40, transcript variant X1
coiled-coil domain containing 40, transcript variant X2
coiled-coil domain containing 40, transcript variant X3
coiled-coil domain-containing protein 40 isoform X1
coiled-coil domain-containing protein 40 isoform X4
coiled-coil domain-containing protein 40 isoform X2
coiled-coil domain-containing protein 40 isoform X3
solute carrier family 26 member 11, transcript variant X1
solute carrier family 26 member 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
solute carrier family 26 member 11, transcript variant X3
solute carrier family 26 member 11, transcript variant X4
sodium-independent sulfate anion transporter isoform X1
sodium-independent sulfate anion transporter isoform X3
sodium-independent sulfate anion transporter isoform X4
sodium-independent sulfate anion transporter isoform X2
ring finger protein 213, transcript variant X2
ring finger protein 213, transcript variant X1
ring finger protein 213, transcript variant X3
ring finger protein 213, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF213 isoform X1
E3 ubiquitin-protein ligase RNF213 isoform X2
E3 ubiquitin-protein ligase RNF213 isoform X3
neuronal pentraxin 1, transcript variant X2
neuronal pentraxin 1, transcript variant X3
neuronal pentraxin 1, transcript variant X1
regulatory associated protein of MTOR complex 1, transcript variant X1
regulatory associated protein of MTOR complex 1, transcript variant X2
regulatory-associated protein of mTOR isoform X1
regulatory-associated protein of mTOR isoform X2
BAR/IMD domain containing adaptor protein 2, transcript variant X3
BAR/IMD domain containing adaptor protein 2, transcript variant X1
BAR/IMD domain containing adaptor protein 2, transcript variant X7
BAR/IMD domain containing adaptor protein 2, transcript variant X4
BAR/IMD domain containing adaptor protein 2, transcript variant X5
BAR/IMD domain containing adaptor protein 2, transcript variant X2
BAR/IMD domain containing adaptor protein 2, transcript variant X6
BAR/IMD domain containing adaptor protein 2, transcript variant X8
brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X1
brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X4
brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X5
brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X3
brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X7
brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X2
brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X6
brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X8
apoptosis associated tyrosine kinase, transcript variant X4
apoptosis associated tyrosine kinase, transcript variant X2
apoptosis associated tyrosine kinase, transcript variant X6
apoptosis associated tyrosine kinase, transcript variant X7
apoptosis associated tyrosine kinase, transcript variant X10
apoptosis associated tyrosine kinase, transcript variant X9
apoptosis associated tyrosine kinase, transcript variant X8
apoptosis associated tyrosine kinase, transcript variant X5
apoptosis associated tyrosine kinase, transcript variant X3
apoptosis associated tyrosine kinase, transcript variant X1
apoptosis associated tyrosine kinase, transcript variant X11
serine/threonine-protein kinase LMTK1 isoform X4
serine/threonine-protein kinase LMTK1 isoform X3
serine/threonine-protein kinase LMTK1 isoform X7
serine/threonine-protein kinase LMTK1 isoform X6
serine/threonine-protein kinase LMTK1 isoform X5
serine/threonine-protein kinase LMTK1 isoform X2
serine/threonine-protein kinase LMTK1 isoform X1
serine/threonine-protein kinase LMTK1 isoform X8
centrosomal protein 131, transcript variant X3
centrosomal protein 131, transcript variant X6
centrosomal protein 131, transcript variant X2
centrosomal protein 131, transcript variant X4
centrosomal protein 131, transcript variant X1
centrosomal protein of 131 kDa isoform X3
centrosomal protein of 131 kDa isoform X5
centrosomal protein of 131 kDa isoform X2
centrosomal protein of 131 kDa isoform X4
centrosomal protein of 131 kDa isoform X1
centrosomal protein 131, transcript variant X5
TEPSIN adaptor related protein complex 4 accessory protein, transcript variant X2
TEPSIN adaptor related protein complex 4 accessory protein, transcript variant X1
AP-4 complex accessory subunit tepsin isoform X2
AP-4 complex accessory subunit tepsin isoform X1
NADH:ubiquinone oxidoreductase complex assembly factor 8
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 8
putative sodium-coupled neutral amino acid transporter 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: BAH and coiled-coil domain-containing protein 1
fascin actin-bundling protein 2, retinal
FA core complex associated protein 100, transcript variant X2
FA core complex associated protein 100, transcript variant X1
Fanconi anemia core complex-associated protein 100
NPL4 homolog, ubiquitin recognition factor
nuclear protein localization protein 4 homolog
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma
oxidoreductase-like domain-containing protein 1
coiled-coil domain containing 137, transcript variant X1
coiled-coil domain containing 137, transcript variant X2
coiled-coil domain-containing protein 137 isoform X1
coiled-coil domain-containing protein 137 isoform X2
G protein-coupled receptor class C group 5 member C, transcript variant X2
G protein-coupled receptor class C group 5 member C, transcript variant X3
G protein-coupled receptor class C group 5 member C, transcript variant X1
G-protein coupled receptor family C group 5 member C isoform X1
G-protein coupled receptor family C group 5 member C isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tweety family member 2, transcript variant X2
tweety family member 2, transcript variant X4
tweety family member 2, transcript variant X1
tweety family member 2, transcript variant X3
sidekick cell adhesion molecule 2, transcript variant X1
sidekick cell adhesion molecule 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
sidekick cell adhesion molecule 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
CDC42 effector protein 4, transcript variant X3
CDC42 effector protein 4, transcript variant X1
CDC42 effector protein 4, transcript variant X2
cleavage and polyadenylation specific factor 4 like
putative cleavage and polyadenylation specificity factor subunit 4-like protein
chromosome 19 C17orf80 homolog, transcript variant X2
chromosome 19 C17orf80 homolog, transcript variant X1
uncharacterized protein C17orf80 homolog isoform X2
uncharacterized protein C17orf80 homolog isoform X1
family with sequence similarity 104 member A, transcript variant X2
family with sequence similarity 104 member A, transcript variant X1
family with sequence similarity 104 member A, transcript variant X3
component of oligomeric golgi complex 1, transcript variant X2
component of oligomeric golgi complex 1, transcript variant X1
component of oligomeric golgi complex 1, transcript variant X3
conserved oligomeric Golgi complex subunit 1 isoform X2
conserved oligomeric Golgi complex subunit 1 isoform X1
conserved oligomeric Golgi complex subunit 1 isoform X3
somatostatin receptor 2, transcript variant X2
somatostatin receptor 2, transcript variant X1
LOW QUALITY PROTEIN: zinc transporter ZIP11
E3 ubiquitin-protein ligase RNF113A-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase RNF113A-like
uncharacterized LOC125336067, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125336067, transcript variant X1
uncharacterized LOC125335870, transcript variant X2
uncharacterized LOC125335870, transcript variant X1
potassium inwardly rectifying channel subfamily J member 2
potassium inwardly rectifying channel subfamily J member 16, transcript variant X2
potassium inwardly rectifying channel subfamily J member 16, transcript variant X1
potassium inwardly rectifying channel subfamily J member 16, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium inwardly rectifying channel subfamily J member 16, transcript variant X3
mitogen-activated protein kinase kinase 6
dual specificity mitogen-activated protein kinase kinase 6
ATP binding cassette subfamily A member 5, transcript variant X2
ATP binding cassette subfamily A member 5, transcript variant X1
ATP-binding cassette sub-family A member 9-like, transcript variant X1
ATP-binding cassette sub-family A member 9-like isoform X1
ATP-binding cassette sub-family A member 9-like, transcript variant X2
ATP-binding cassette sub-family A member 9-like isoform X2
ATP-binding cassette sub-family A member 10-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ATP-binding cassette sub-family A member 10-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ATP-binding cassette sub-family A member 10-like, transcript variant X2
ATP-binding cassette sub-family A member 10-like, transcript variant X1
ATP-binding cassette sub-family A member 10-like isoform X1
ATP-binding cassette sub-family A member 10-like isoform X2
ATP-binding cassette sub-family A member 9-like isoform X3
uncharacterized LOC125335849, transcript variant X1
uncharacterized LOC125335849, transcript variant X2
FAM20A golgi associated secretory pathway pseudokinase
protein kinase cAMP-dependent type I regulatory subunit alpha, transcript variant X2
protein kinase cAMP-dependent type I regulatory subunit alpha, transcript variant X1
cAMP-dependent protein kinase type I-alpha regulatory subunit
WD repeat domain, phosphoinositide interacting 1
WD repeat domain phosphoinositide-interacting protein 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
solute carrier family 16 member 6, transcript variant X1
monocarboxylate transporter 7 isoform X1
solute carrier family 16 member 6, transcript variant X2
monocarboxylate transporter 7 isoform X2
guanine nucleotide-binding protein subunit alpha-13
regulator of G protein signaling 9, transcript variant X3
regulator of G protein signaling 9, transcript variant X1
regulator of G-protein signaling 9 isoform X1
regulator of G-protein signaling 9 isoform X3
regulator of G protein signaling 9, transcript variant X2
regulator of G-protein signaling 9 isoform X2
centrosomal protein 112, transcript variant X4
centrosomal protein 112, transcript variant X2
centrosomal protein 112, transcript variant X3
centrosomal protein 112, transcript variant X1
centrosomal protein 112, transcript variant X5
centrosomal protein of 112 kDa isoform X3
centrosomal protein of 112 kDa isoform X5
centrosomal protein of 112 kDa isoform X2
centrosomal protein of 112 kDa isoform X4
centrosomal protein of 112 kDa isoform X1
centrosomal protein 112, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
centrosomal protein of 112 kDa isoform X6
protein kinase C alpha, transcript variant X1
protein kinase C alpha, transcript variant X2
calcium voltage-gated channel auxiliary subunit gamma 5, transcript variant X3
calcium voltage-gated channel auxiliary subunit gamma 5, transcript variant X4
calcium voltage-gated channel auxiliary subunit gamma 5, transcript variant X5
calcium voltage-gated channel auxiliary subunit gamma 5, transcript variant X6
calcium voltage-gated channel auxiliary subunit gamma 5, transcript variant X1
calcium voltage-gated channel auxiliary subunit gamma 5, transcript variant X7
calcium voltage-gated channel auxiliary subunit gamma 5, transcript variant X2
voltage-dependent calcium channel gamma-5 subunit
calcium voltage-gated channel auxiliary subunit gamma 4
voltage-dependent calcium channel gamma-4 subunit
calcium voltage-gated channel auxiliary subunit gamma 1
voltage-dependent calcium channel gamma-1 subunit
helicase with zinc finger, transcript variant X3
helicase with zinc finger, transcript variant X2
helicase with zinc finger, transcript variant X1
helicase with zinc finger, transcript variant X4
probable helicase with zinc finger domain isoform X3
probable helicase with zinc finger domain isoform X2
probable helicase with zinc finger domain isoform X1
probable helicase with zinc finger domain isoform X4
proteasome 26S subunit, non-ATPase 12, transcript variant X1
26S proteasome non-ATPase regulatory subunit 12 isoform X1
proteasome 26S subunit, non-ATPase 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 12 isoform X2
phosphatidylinositol transfer protein cytoplasmic 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
phosphatidylinositol transfer protein cytoplasmic 1, transcript variant X3
phosphatidylinositol transfer protein cytoplasmic 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
phosphatidylinositol transfer protein cytoplasmic 1, transcript variant X1
cytoplasmic phosphatidylinositol transfer protein 1 isoform X1
cytoplasmic phosphatidylinositol transfer protein 1 isoform X3
cytoplasmic phosphatidylinositol transfer protein 1 isoform X2
cytoplasmic phosphatidylinositol transfer protein 1 isoform X4
bromodomain PHD finger transcription factor, transcript variant X3
bromodomain PHD finger transcription factor, transcript variant X7
bromodomain PHD finger transcription factor, transcript variant X1
bromodomain PHD finger transcription factor, transcript variant X2
bromodomain PHD finger transcription factor, transcript variant X10
bromodomain PHD finger transcription factor, transcript variant X4
bromodomain PHD finger transcription factor, transcript variant X8
bromodomain PHD finger transcription factor, transcript variant X6
bromodomain PHD finger transcription factor, transcript variant X5
bromodomain PHD finger transcription factor, transcript variant X9
nucleosome-remodeling factor subunit BPTF isoform X1
nucleosome-remodeling factor subunit BPTF isoform X7
nucleosome-remodeling factor subunit BPTF isoform X2
nucleosome-remodeling factor subunit BPTF isoform X6
nucleosome-remodeling factor subunit BPTF isoform X5
nucleosome-remodeling factor subunit BPTF isoform X9
nucleosome-remodeling factor subunit BPTF isoform X10
nucleosome-remodeling factor subunit BPTF isoform X4
nucleosome-remodeling factor subunit BPTF isoform X8
nucleosome-remodeling factor subunit BPTF isoform X3
uncharacterized LOC125336030, transcript variant X2
uncharacterized LOC125336030, transcript variant X1
chromosome 19 C17orf58 homolog, transcript variant X5
chromosome 19 C17orf58 homolog, transcript variant X4
chromosome 19 C17orf58 homolog, transcript variant X2
chromosome 19 C17orf58 homolog, transcript variant X3
chromosome 19 C17orf58 homolog, transcript variant X1
UPF0450 protein C17orf58 homolog isoform X4
UPF0450 protein C17orf58 homolog isoform X3
UPF0450 protein C17orf58 homolog isoform X2
UPF0450 protein C17orf58 homolog isoform X1
UPF0450 protein C17orf58 homolog isoform X5
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon CCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
karyopherin subunit alpha 2, transcript variant X1
karyopherin subunit alpha 2, transcript variant X3
karyopherin subunit alpha 2, transcript variant X2
SMAD specific E3 ubiquitin protein ligase 2, transcript variant X2
E3 ubiquitin-protein ligase SMURF2 isoform X2
SMAD specific E3 ubiquitin protein ligase 2, transcript variant X1
E3 ubiquitin-protein ligase SMURF2 isoform X1
centrosomal protein 95, transcript variant X3
centrosomal protein 95, transcript variant X2
centrosomal protein 95, transcript variant X1
centrosomal protein of 95 kDa isoform X2
centrosomal protein of 95 kDa isoform X1
DEAD-box helicase 5, transcript variant X2
DEAD-box helicase 5, transcript variant X1
probable ATP-dependent RNA helicase DDX5 isoform X1
probable ATP-dependent RNA helicase DDX5 isoform X2
DNA polymerase gamma 2, accessory subunit, transcript variant X2
DNA polymerase gamma 2, accessory subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
DNA polymerase gamma 2, accessory subunit, transcript variant X1
DNA polymerase subunit gamma-2, mitochondrial isoform X1
DNA polymerase subunit gamma-2, mitochondrial isoform X2
DNA polymerase subunit gamma-2, mitochondrial isoform X3
mast cell immunoglobulin like receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
mast cell immunoglobulin like receptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X1
platelet and endothelial cell adhesion molecule 1, transcript variant X4
platelet and endothelial cell adhesion molecule 1, transcript variant X6
platelet and endothelial cell adhesion molecule 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X13
platelet and endothelial cell adhesion molecule 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X18
platelet and endothelial cell adhesion molecule 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X24
platelet and endothelial cell adhesion molecule 1, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
platelet and endothelial cell adhesion molecule 1, transcript variant X23
platelet and endothelial cell adhesion molecule 1, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
platelet endothelial cell adhesion molecule isoform X1
platelet endothelial cell adhesion molecule isoform X4
platelet endothelial cell adhesion molecule isoform X6
platelet endothelial cell adhesion molecule isoform X3
platelet endothelial cell adhesion molecule isoform X10
platelet endothelial cell adhesion molecule isoform X13
platelet endothelial cell adhesion molecule isoform X14
platelet endothelial cell adhesion molecule isoform X18
platelet endothelial cell adhesion molecule isoform X15
platelet endothelial cell adhesion molecule isoform X19
platelet endothelial cell adhesion molecule isoform X9
platelet endothelial cell adhesion molecule isoform X12
platelet endothelial cell adhesion molecule isoform X17
platelet endothelial cell adhesion molecule isoform X2
platelet endothelial cell adhesion molecule isoform X5
platelet endothelial cell adhesion molecule isoform X7
platelet endothelial cell adhesion molecule isoform X8
platelet endothelial cell adhesion molecule isoform X11
platelet endothelial cell adhesion molecule isoform X16
platelet endothelial cell adhesion molecule isoform X20
testis expressed 2, transcript variant X6
testis expressed 2, transcript variant X3
testis expressed 2, transcript variant X2
testis expressed 2, transcript variant X4
testis expressed 2, transcript variant X5
testis expressed 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00598
COORDINATES: nucleotide motif:Rfam:12.0:RF00289
endoplasmic reticulum to nucleus signaling 1, transcript variant X3
serine/threonine-protein kinase/endoribonuclease IRE1 isoform X3
endoplasmic reticulum to nucleus signaling 1, transcript variant X1
endoplasmic reticulum to nucleus signaling 1, transcript variant X2
serine/threonine-protein kinase/endoribonuclease IRE1 isoform X1
serine/threonine-protein kinase/endoribonuclease IRE1 isoform X2
endoplasmic reticulum to nucleus signaling 1, transcript variant X4
serine/threonine-protein kinase/endoribonuclease IRE1 isoform X4
endoplasmic reticulum to nucleus signaling 1, transcript variant X5
serine/threonine-protein kinase/endoribonuclease IRE1 isoform X5
sterile alpha motif domain-containing protein 9-like, transcript variant X3
sterile alpha motif domain-containing protein 9-like, transcript variant X2
sterile alpha motif domain-containing protein 9-like, transcript variant X1
sterile alpha motif domain-containing protein 9-like isoform X1
sterile alpha motif domain-containing protein 9-like isoform X2
zinc finger protein 207, transcript variant X8
zinc finger protein 207, transcript variant X5
zinc finger protein 207, transcript variant X4
zinc finger protein 207, transcript variant X7
zinc finger protein 207, transcript variant X3
zinc finger protein 207, transcript variant X6
zinc finger protein 207, transcript variant X2
zinc finger protein 207, transcript variant X1
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X7
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X4
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X3
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X6
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X2
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X5
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X1
chromosome 19 C17orf75 homolog, transcript variant X1
chromosome 19 C17orf75 homolog, transcript variant X3
chromosome 19 C17orf75 homolog, transcript variant X2
chromosome 19 C17orf75 homolog, transcript variant X4
ras homolog family member T1, transcript variant X3
ras homolog family member T1, transcript variant X1
ras homolog family member T1, transcript variant X2
ArfGAP with dual PH domains 2, transcript variant X5
ArfGAP with dual PH domains 2, transcript variant X2
ArfGAP with dual PH domains 2, transcript variant X3
ArfGAP with dual PH domains 2, transcript variant X4
ArfGAP with dual PH domains 2, transcript variant X1
arf-GAP with dual PH domain-containing protein 2 isoform X5
arf-GAP with dual PH domain-containing protein 2 isoform X2
arf-GAP with dual PH domain-containing protein 2 isoform X3
arf-GAP with dual PH domain-containing protein 2 isoform X4
arf-GAP with dual PH domain-containing protein 2 isoform X1
ATPase family AAA domain containing 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ATPase family AAA domain-containing protein 5 isoform X1
ATPase family AAA domain containing 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ATPase family AAA domain-containing protein 5 isoform X2
cytokine receptor like factor 3, transcript variant X1
cytokine receptor-like factor 3 isoform X1
cytokine receptor like factor 3, transcript variant X2
cytokine receptor-like factor 3 isoform X2
SUZ12 polycomb repressive complex 2 subunit
U3 small nucleolar RNA-associated protein 6 homolog
coordinator of PRMT5 and differentiation stimulator, transcript variant X3
coordinator of PRMT5 and differentiation stimulator, transcript variant X1
coordinator of PRMT5 and differentiation stimulator, transcript variant X2
coordinator of PRMT5 and differentiation stimulator isoform X1
coordinator of PRMT5 and differentiation stimulator isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transfer RNA threonine (anticodon CGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
RAB11 family interacting protein 4, transcript variant X3
RAB11 family interacting protein 4, transcript variant X2
RAB11 family interacting protein 4, transcript variant X1
RAB11 family interacting protein 4, transcript variant X4
rab11 family-interacting protein 4 isoform X3
rab11 family-interacting protein 4 isoform X2
rab11 family-interacting protein 4 isoform X1
rab11 family-interacting protein 4 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
retinoid-inducible serine carboxypeptidase
diacylglycerol kinase epsilon, transcript variant X1
diacylglycerol kinase epsilon, transcript variant X2
diacylglycerol kinase epsilon isoform X2
diacylglycerol kinase epsilon isoform X1
diacylglycerol kinase epsilon, transcript variant X3
uncharacterized protein C17orf67 homolog
ankyrin repeat and fibronectin type III domain containing 1, transcript variant X2
ankyrin repeat and fibronectin type III domain containing 1, transcript variant X1
ankyrin repeat and fibronectin type-III domain-containing protein 1 isoform X1
ankyrin repeat and fibronectin type-III domain-containing protein 1 isoform X2
phosphatidylcholine transfer protein, transcript variant X1
phosphatidylcholine transfer protein, transcript variant X2
phosphatidylcholine transfer protein isoform X2
phosphatidylcholine transfer protein isoform X1
transmembrane protein 100, transcript variant X4
transmembrane protein 100, transcript variant X1
transmembrane protein 100, transcript variant X3
transmembrane protein 100, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
monocyte to macrophage differentiation associated, transcript variant X1
monocyte to macrophage differentiation associated, transcript variant X2
monocyte to macrophage differentiation factor isoform X1
monocyte to macrophage differentiation factor isoform X2
monocyte to macrophage differentiation associated, transcript variant X3
monocyte to macrophage differentiation factor isoform X3
HLF transcription factor, PAR bZIP family member
syntaxin binding protein 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
syntaxin binding protein 4, transcript variant X4
syntaxin binding protein 4, transcript variant X2
syntaxin binding protein 4, transcript variant X1
cytochrome c oxidase assembly protein COX11, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: cytochrome c oxidase assembly protein COX11, mitochondrial
target of myb1 like 1 membrane trafficking protein, transcript variant X1
target of myb1 like 1 membrane trafficking protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
UTP18 small subunit processome component
U3 small nucleolar RNA-associated protein 18 homolog
mbt domain containing 1, transcript variant X1
mbt domain containing 1, transcript variant X3
mbt domain containing 1, transcript variant X5
mbt domain containing 1, transcript variant X11
mbt domain containing 1, transcript variant X13
mbt domain containing 1, transcript variant X9
mbt domain containing 1, transcript variant X2
mbt domain containing 1, transcript variant X4
mbt domain containing 1, transcript variant X6
mbt domain containing 1, transcript variant X7
MBT domain-containing protein 1 isoform X1
MBT domain-containing protein 1 isoform X4
MBT domain-containing protein 1 isoform X2
MBT domain-containing protein 1 isoform X6
MBT domain-containing protein 1 isoform X3
MBT domain-containing protein 1 isoform X5
MBT domain-containing protein 1 isoform X7
mbt domain containing 1, transcript variant X8
mbt domain containing 1, transcript variant X10
mbt domain containing 1, transcript variant X12
MBT domain-containing protein 1 isoform X8
sperm associated antigen 9, transcript variant X1
sperm associated antigen 9, transcript variant X4
sperm associated antigen 9, transcript variant X2
sperm associated antigen 9, transcript variant X3
sperm associated antigen 9, transcript variant X5
sperm associated antigen 9, transcript variant X6
sperm associated antigen 9, transcript variant X7
C-Jun-amino-terminal kinase-interacting protein 4 isoform X1
C-Jun-amino-terminal kinase-interacting protein 4 isoform X4
C-Jun-amino-terminal kinase-interacting protein 4 isoform X2
C-Jun-amino-terminal kinase-interacting protein 4 isoform X6
C-Jun-amino-terminal kinase-interacting protein 4 isoform X3
C-Jun-amino-terminal kinase-interacting protein 4 isoform X5
C-Jun-amino-terminal kinase-interacting protein 4 isoform X7
sperm associated antigen 9, transcript variant X8
sperm associated antigen 9, transcript variant X9
sperm associated antigen 9, transcript variant X10
sperm associated antigen 9, transcript variant X11
C-Jun-amino-terminal kinase-interacting protein 4 isoform X8
C-Jun-amino-terminal kinase-interacting protein 4 isoform X10
C-Jun-amino-terminal kinase-interacting protein 4 isoform X9
C-Jun-amino-terminal kinase-interacting protein 4 isoform X11
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2
WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2
ankyrin repeat domain-containing protein 40-like
LUC7 like 3 pre-mRNA splicing factor, transcript variant X3
LUC7 like 3 pre-mRNA splicing factor, transcript variant X2
LUC7 like 3 pre-mRNA splicing factor, transcript variant X1
LUC7 like 3 pre-mRNA splicing factor, transcript variant X4
LUC7 like 3 pre-mRNA splicing factor, transcript variant X5
ankyrin repeat domain 40, transcript variant X1
ankyrin repeat domain-containing protein 40 isoform X1
ankyrin repeat domain 40, transcript variant X2
ankyrin repeat domain 40, transcript variant X3
ankyrin repeat domain 40, transcript variant X4
ankyrin repeat domain-containing protein 40 isoform X3
ankyrin repeat domain-containing protein 40 isoform X4
ankyrin repeat domain-containing protein 40 isoform X2
ATP binding cassette subfamily C member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ATP-binding cassette sub-family C member 3 isoform X1
ATP binding cassette subfamily C member 3, transcript variant X2
ATP-binding cassette sub-family C member 3 isoform X2
calcium voltage-gated channel subunit alpha1 G, transcript variant X11
calcium voltage-gated channel subunit alpha1 G, transcript variant X8
calcium voltage-gated channel subunit alpha1 G, transcript variant X6
calcium voltage-gated channel subunit alpha1 G, transcript variant X3
calcium voltage-gated channel subunit alpha1 G, transcript variant X9
calcium voltage-gated channel subunit alpha1 G, transcript variant X7
calcium voltage-gated channel subunit alpha1 G, transcript variant X2
calcium voltage-gated channel subunit alpha1 G, transcript variant X5
calcium voltage-gated channel subunit alpha1 G, transcript variant X23
calcium voltage-gated channel subunit alpha1 G, transcript variant X4
calcium voltage-gated channel subunit alpha1 G, transcript variant X10
calcium voltage-gated channel subunit alpha1 G, transcript variant X13
calcium voltage-gated channel subunit alpha1 G, transcript variant X1
calcium voltage-gated channel subunit alpha1 G, transcript variant X18
calcium voltage-gated channel subunit alpha1 G, transcript variant X24
calcium voltage-gated channel subunit alpha1 G, transcript variant X14
calcium voltage-gated channel subunit alpha1 G, transcript variant X12
calcium voltage-gated channel subunit alpha1 G, transcript variant X15
calcium voltage-gated channel subunit alpha1 G, transcript variant X22
calcium voltage-gated channel subunit alpha1 G, transcript variant X19
calcium voltage-gated channel subunit alpha1 G, transcript variant X17
calcium voltage-gated channel subunit alpha1 G, transcript variant X16
calcium voltage-gated channel subunit alpha1 G, transcript variant X21
calcium voltage-gated channel subunit alpha1 G, transcript variant X20
voltage-dependent T-type calcium channel subunit alpha-1G isoform X22
voltage-dependent T-type calcium channel subunit alpha-1G isoform X19
voltage-dependent T-type calcium channel subunit alpha-1G isoform X20
voltage-dependent T-type calcium channel subunit alpha-1G isoform X17
voltage-dependent T-type calcium channel subunit alpha-1G isoform X8
voltage-dependent T-type calcium channel subunit alpha-1G isoform X6
voltage-dependent T-type calcium channel subunit alpha-1G isoform X18
voltage-dependent T-type calcium channel subunit alpha-1G isoform X24
voltage-dependent T-type calcium channel subunit alpha-1G isoform X14
voltage-dependent T-type calcium channel subunit alpha-1G isoform X16
voltage-dependent T-type calcium channel subunit alpha-1G isoform X12
voltage-dependent T-type calcium channel subunit alpha-1G isoform X3
voltage-dependent T-type calcium channel subunit alpha-1G isoform X15
voltage-dependent T-type calcium channel subunit alpha-1G isoform X9
voltage-dependent T-type calcium channel subunit alpha-1G isoform X7
voltage-dependent T-type calcium channel subunit alpha-1G isoform X2
voltage-dependent T-type calcium channel subunit alpha-1G isoform X5
voltage-dependent T-type calcium channel subunit alpha-1G isoform X23
voltage-dependent T-type calcium channel subunit alpha-1G isoform X4
voltage-dependent T-type calcium channel subunit alpha-1G isoform X21
voltage-dependent T-type calcium channel subunit alpha-1G isoform X10
voltage-dependent T-type calcium channel subunit alpha-1G isoform X13
voltage-dependent T-type calcium channel subunit alpha-1G isoform X11
voltage-dependent T-type calcium channel subunit alpha-1G isoform X1
calcium voltage-gated channel subunit alpha1 G, transcript variant X25
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
voltage-dependent T-type calcium channel subunit alpha-1G isoform X25
spermatogenesis associated 20, transcript variant X4
spermatogenesis associated 20, transcript variant X2
spermatogenesis associated 20, transcript variant X1
spermatogenesis associated 20, transcript variant X3
spermatogenesis-associated protein 20 isoform X1
spermatogenesis-associated protein 20 isoform X2
spermatogenesis-associated protein 20 isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
MYCBP associated protein, transcript variant X2
MYCBP associated protein, transcript variant X1
MYCBP associated protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
radical S-adenosyl methionine domain containing 1
radical S-adenosyl methionine domain-containing protein 1, mitochondrial
medium-chain acyl-CoA ligase ACSF2, mitochondrial
leucine-rich repeat-containing protein 59
essential meiotic structure-specific endonuclease 1
39S ribosomal protein L27, mitochondrial
CMRF35-like molecule 5, transcript variant X1
CMRF35-like molecule 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
RAB37, member RAS oncogene family, transcript variant X1
RAB37, member RAS oncogene family, transcript variant X2
RAB37, member RAS oncogene family, transcript variant X3
Na(+)/H(+) exchange regulatory cofactor NHE-RF1
N-acetyltransferase 9 (putative), transcript variant X3
N-acetyltransferase 9 (putative), transcript variant X1
N-acetyltransferase 9 (putative), transcript variant X2
N-acetyltransferase 9 (putative), transcript variant X4
transmembrane protein 104, transcript variant X1
transmembrane protein 104, transcript variant X3
transmembrane protein 104, transcript variant X2
glutamate ionotropic receptor NMDA type subunit 2C
NADPH:adrenodoxin oxidoreductase, mitochondrial
fatty acid desaturase 6, transcript variant X2
fatty acid desaturase 6, transcript variant X1
USH1 protein network component sans, transcript variant X1
Usher syndrome type-1G protein isoform X1
USH1 protein network component sans, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
Usher syndrome type-1G protein isoform X2
cerebellar degeneration related protein 2 like
cerebellar degeneration-related protein 2-like
peptidyl-tRNA hydrolase ICT1, mitochondrial
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
potassium channel tetramerization domain containing 2
solute carrier family 16 member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 16 member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
5'(3')-deoxyribonucleotidase, cytosolic type
Jupiter microtubule associated homolog 1
golgi associated, gamma adaptin ear containing, ARF binding protein 3
ADP-ribosylation factor-binding protein GGA3
solute carrier family 25 member 19, transcript variant X1
solute carrier family 25 member 19, transcript variant X2
mitochondrial thiamine pyrophosphate carrier
transmembrane protein 94, transcript variant X2
transmembrane protein 94, transcript variant X1
transmembrane protein 94, transcript variant X4
transmembrane protein 94, transcript variant X3
transmembrane protein 94, transcript variant X5
CASK interacting protein 2, transcript variant X2
CASK interacting protein 2, transcript variant X1
CASK interacting protein 2, transcript variant X5
CASK interacting protein 2, transcript variant X4
CASK interacting protein 2, transcript variant X7
CASK interacting protein 2, transcript variant X3
CASK interacting protein 2, transcript variant X6
melanin-concentrating hormone receptor 1-like, transcript variant X1
melanin-concentrating hormone receptor 1-like, transcript variant X2
melanin-concentrating hormone receptor 1-like isoform X1
melanin-concentrating hormone receptor 1-like isoform X2
tRNA splicing endonuclease subunit 54, transcript variant X1
tRNA splicing endonuclease subunit 54, transcript variant X2
tRNA splicing endonuclease subunit 54, transcript variant X3
tRNA-splicing endonuclease subunit Sen54 isoform X1
tRNA-splicing endonuclease subunit Sen54 isoform X2
LLGL scribble cell polarity complex component 2, transcript variant X1
LLGL scribble cell polarity complex component 2, transcript variant X2
LLGL scribble cell polarity complex component 2, transcript variant X3
LLGL scribble cell polarity complex component 2, transcript variant X5
LLGL scribble cell polarity complex component 2, transcript variant X6
LLGL scribble cell polarity complex component 2, transcript variant X4
LLGL scribble cell polarity complex component 2 isoform X4
LLGL scribble cell polarity complex component 2 isoform X5
LLGL scribble cell polarity complex component 2 isoform X1
LLGL scribble cell polarity complex component 2 isoform X2
LLGL scribble cell polarity complex component 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
unconventional myosin-XVB-like, transcript variant X4
unconventional myosin-XVB-like isoform X3
unconventional myosin-XVB-like, transcript variant X2
unconventional myosin-XVB-like, transcript variant X3
unconventional myosin-XVB-like isoform X2
unconventional myosin-XVB-like, transcript variant X1
unconventional myosin-XVB-like isoform X1
RecQ like helicase 5, transcript variant X4
RecQ like helicase 5, transcript variant X1
RecQ like helicase 5, transcript variant X2
RecQ like helicase 5, transcript variant X5
RecQ like helicase 5, transcript variant X3
RecQ like helicase 5, transcript variant X6
ATP-dependent DNA helicase Q5 isoform X1
ATP-dependent DNA helicase Q5 isoform X2
ATP-dependent DNA helicase Q5 isoform X3
small integral membrane protein 5, transcript variant X3
small integral membrane protein 5, transcript variant X4
small integral membrane protein 5, transcript variant X1
small integral membrane protein 5, transcript variant X2
small integral membrane protein 5, transcript variant X5
SAP30 binding protein, transcript variant X1
SAP30 binding protein, transcript variant X2
integrin subunit beta 4, transcript variant X1
integrin subunit beta 4, transcript variant X2
integrin subunit beta 4, transcript variant X3
integrin subunit beta 4, transcript variant X4
RING finger protein unkempt homolog isoform X1
RING finger protein unkempt homolog isoform X4
RING finger protein unkempt homolog isoform X8
RING finger protein unkempt homolog isoform X5
RING finger protein unkempt homolog isoform X6
RING finger protein unkempt homolog isoform X2
RING finger protein unkempt homolog isoform X7
RING finger protein unkempt homolog isoform X3
WW domain binding protein 2, transcript variant X2
WW domain binding protein 2, transcript variant X1
WW domain binding protein 2, transcript variant X3
WW domain binding protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
39S ribosomal protein L38, mitochondrial
acyl-CoA oxidase 1, transcript variant X2
acyl-CoA oxidase 1, transcript variant X1
peroxisomal acyl-coenzyme A oxidase 1 isoform X1
peroxisomal acyl-coenzyme A oxidase 1 isoform X2
TEN1 subunit of CST complex, transcript variant X1
TEN1 subunit of CST complex, transcript variant X2
TEN1 subunit of CST complex, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
collagen alpha-1(I) chain-like, transcript variant X2
collagen alpha-1(I) chain-like, transcript variant X1
collagen alpha-1(I) chain-like, transcript variant X3
collagen alpha-1(I) chain-like, transcript variant X4
signal recognition particle subunit SRP68
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
exocyst complex component 7, transcript variant X12
exocyst complex component 7, transcript variant X11
exocyst complex component 7, transcript variant X8
exocyst complex component 7, transcript variant X4
exocyst complex component 7, transcript variant X2
exocyst complex component 7, transcript variant X7
exocyst complex component 7, transcript variant X5
exocyst complex component 7, transcript variant X3
exocyst complex component 7, transcript variant X1
exocyst complex component 7, transcript variant X13
exocyst complex component 7, transcript variant X10
exocyst complex component 7, transcript variant X6
exocyst complex component 7, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
ring finger protein 157, transcript variant X5
ring finger protein 157, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
ring finger protein 157, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
ring finger protein 157, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
ring finger protein 157, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ring finger protein 157, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
ring finger protein 157, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X6
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X3
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X1
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X2
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X7
phosphoribosyl pyrophosphate synthase-associated protein 1 isoform X1
phosphoribosyl pyrophosphate synthase-associated protein 1 isoform X2
phosphoribosyl pyrophosphate synthase-associated protein 1 isoform X3
phosphoribosyl pyrophosphate synthase-associated protein 1 isoform X5
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
phosphoribosyl pyrophosphate synthetase associated protein 1, transcript variant X4
phosphoribosyl pyrophosphate synthase-associated protein 1 isoform X4
(E3-independent) E2 ubiquitin-conjugating enzyme
LOW QUALITY PROTEIN: inactive rhomboid protein 2
COORDINATES: nucleotide motif:Rfam:12.0:RF00213
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1, transcript variant X2
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1, transcript variant X1
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 isoform X1
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 isoform X2
matrix remodeling associated 7, transcript variant X1
matrix-remodeling-associated protein 7 isoform X1
matrix remodeling associated 7, transcript variant X6
matrix remodeling associated 7, transcript variant X4
matrix remodeling associated 7, transcript variant X9
matrix remodeling associated 7, transcript variant X3
matrix remodeling associated 7, transcript variant X5
matrix remodeling associated 7, transcript variant X2
matrix remodeling associated 7, transcript variant X8
matrix remodeling associated 7, transcript variant X7
matrix-remodeling-associated protein 7 isoform X7
matrix-remodeling-associated protein 7 isoform X3
matrix-remodeling-associated protein 7 isoform X2
matrix-remodeling-associated protein 7 isoform X6
matrix-remodeling-associated protein 7 isoform X8
matrix-remodeling-associated protein 7 isoform X5
matrix-remodeling-associated protein 7 isoform X4
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
bifunctional arginine demethylase and lysyl-hydroxylase JMJD6
probable methyltransferase-like protein 23
serine and arginine rich splicing factor 2, transcript variant X5
serine and arginine rich splicing factor 2, transcript variant X3
serine and arginine rich splicing factor 2, transcript variant X4
serine and arginine rich splicing factor 2, transcript variant X2
serine and arginine rich splicing factor 2, transcript variant X1
major facilitator superfamily domain containing 11
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B, transcript variant X1
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B, transcript variant X2
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B isoform X1
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00424
uncharacterized LOC125335879, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC125335879, transcript variant X2
trinucleotide repeat containing adaptor 6C, transcript variant X2
trinucleotide repeat containing adaptor 6C, transcript variant X9
trinucleotide repeat containing adaptor 6C, transcript variant X8
trinucleotide repeat containing adaptor 6C, transcript variant X7
trinucleotide repeat containing adaptor 6C, transcript variant X3
trinucleotide repeat containing adaptor 6C, transcript variant X5
trinucleotide repeat containing adaptor 6C, transcript variant X1
trinucleotide repeat containing adaptor 6C, transcript variant X6
trinucleotide repeat containing adaptor 6C, transcript variant X4
trinucleotide repeat containing adaptor 6C, transcript variant X10
trinucleotide repeat-containing gene 6C protein isoform X2
trinucleotide repeat-containing gene 6C protein isoform X9
trinucleotide repeat-containing gene 6C protein isoform X6
trinucleotide repeat-containing gene 6C protein isoform X8
trinucleotide repeat-containing gene 6C protein isoform X4
trinucleotide repeat-containing gene 6C protein isoform X7
trinucleotide repeat-containing gene 6C protein isoform X3
trinucleotide repeat-containing gene 6C protein isoform X5
trinucleotide repeat-containing gene 6C protein isoform X1
trinucleotide repeat-containing gene 6C protein isoform X10
uncharacterized LOC125335962, transcript variant X2
uncharacterized LOC125335962, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
T-cell antigen CD7-like, transcript variant X4
T-cell antigen CD7-like, transcript variant X3
T-cell antigen CD7-like, transcript variant X2
T-cell antigen CD7-like, transcript variant X1
T-cell antigen CD7-like, transcript variant X5
T-cell antigen CD7-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125335994, transcript variant X1
uncharacterized LOC125335994, transcript variant X2
maestro heat-like repeat-containing protein family member 2A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125335997, transcript variant X1
uncharacterized LOC125335997, transcript variant X2
maestro heat-like repeat family member 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
urotensin-2 receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
urotensin-2 receptor-like, transcript variant X2
2-oxoglutarate and iron dependent oxygenase domain containing 3, transcript variant X2
2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 isoform X2
2-oxoglutarate and iron dependent oxygenase domain containing 3, transcript variant X1
2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 isoform X1
2-oxoglutarate and iron dependent oxygenase domain containing 3, transcript variant X3
2-oxoglutarate and iron dependent oxygenase domain containing 3, transcript variant X4
2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 isoform X3
nuclear prelamin A recognition factor, transcript variant X1
nuclear prelamin A recognition factor, transcript variant X2
transfer RNA glutamine (anticodon UUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
WD repeat domain 45B, transcript variant X2
WD repeat domain 45B, transcript variant X1
WD repeat domain phosphoinositide-interacting protein 3 isoform X2
WD repeat domain phosphoinositide-interacting protein 3 isoform X1
fructosamine 3 kinase, transcript variant X2
fructosamine 3 kinase, transcript variant X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1, transcript variant X5
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1, transcript variant X4
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1, transcript variant X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1, transcript variant X3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1, transcript variant X6
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1, transcript variant X8
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1, transcript variant X7
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 isoform X4
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 isoform X3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 isoform X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 isoform X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 isoform X5
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 isoform X6
meteorin like, glial cell differentiation regulator
uncharacterized LOC125336003, transcript variant X1
uncharacterized LOC125336003, transcript variant X5
uncharacterized LOC125336003, transcript variant X6
uncharacterized LOC125336003, transcript variant X7
uncharacterized LOC125336003, transcript variant X2
uncharacterized LOC125336003, transcript variant X4
uncharacterized LOC125336003, transcript variant X3
heparan sulfate glucosamine 3-O-sulfotransferase 3A1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
coiled-coil domain containing 61, transcript variant X1
coiled-coil domain containing 61, transcript variant X2
coiled-coil domain containing 61, transcript variant X3
biogenesis of lysosomal organelles complex 1 subunit 3, transcript variant X1
biogenesis of lysosomal organelles complex 1 subunit 3, transcript variant X2
biogenesis of lysosome-related organelles complex 1 subunit 3
dehydrogenase/reductase SDR family member 7C
germ cell-specific gene 1-like protein 2
growth arrest specific 7, transcript variant X2
growth arrest specific 7, transcript variant X3
growth arrest specific 7, transcript variant X1
growth arrest specific 7, transcript variant X4
growth arrest-specific protein 7 isoform X2
growth arrest-specific protein 7 isoform X3
growth arrest-specific protein 7 isoform X1
growth arrest-specific protein 7 isoform X4
uncharacterized LOC125335736, transcript variant X1
uncharacterized LOC125335736, transcript variant X2
uncharacterized LOC125335738, transcript variant X1
uncharacterized LOC125335738, transcript variant X2
myosin heavy chain, skeletal muscle, adult-like
myosin heavy chain, skeletal muscle, adult
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 259 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125335737, transcript variant X1
uncharacterized LOC125335737, transcript variant X3
uncharacterized LOC125335737, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ADP-ribose/CDP-alcohol diphosphatase, manganese dependent
manganese-dependent ADP-ribose/CDP-alcohol diphosphatase
transmembrane protein 220, transcript variant X2
transmembrane protein 220, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
transmembrane protein 220, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
mitogen-activated protein kinase kinase 4, transcript variant X1
mitogen-activated protein kinase kinase 4, transcript variant X2
dual specificity mitogen-activated protein kinase kinase 4 isoform X1
dual specificity mitogen-activated protein kinase kinase 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
elaC ribonuclease Z 2, transcript variant X2
elaC ribonuclease Z 2, transcript variant X1
zinc phosphodiesterase ELAC protein 2 isoform X1
zinc phosphodiesterase ELAC protein 2 isoform X2
dynein axonemal heavy chain 9, transcript variant X1
dynein axonemal heavy chain 9 isoform X1
dynein axonemal heavy chain 9, transcript variant X2
dynein axonemal heavy chain 9 isoform X2
dynein axonemal heavy chain 9, transcript variant X4
dynein axonemal heavy chain 9, transcript variant X3
dynein axonemal heavy chain 9 isoform X3
dynein axonemal heavy chain 9 isoform X4
shisa family member 6, transcript variant X2
shisa family member 6, transcript variant X1
phosphoinositide interacting regulator of transient receptor potential channels, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phosphoinositide interacting regulator of transient receptor potential channels, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphoinositide-interacting protein isoform X1
phosphoinositide-interacting protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
nudE neurodevelopment protein 1 like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nudE neurodevelopment protein 1 like 1, transcript variant X7
nudE neurodevelopment protein 1 like 1, transcript variant X6
nudE neurodevelopment protein 1 like 1, transcript variant X5
nudE neurodevelopment protein 1 like 1, transcript variant X2
nudE neurodevelopment protein 1 like 1, transcript variant X3
nuclear distribution protein nudE-like 1 isoform X3
nuclear distribution protein nudE-like 1 isoform X2
nudE neurodevelopment protein 1 like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
nuclear distribution protein nudE-like 1 isoform X1
nuclear distribution protein nudE-like 1 isoform X4
myosin heavy chain 10, transcript variant X1
myosin heavy chain 10, transcript variant X4
myosin heavy chain 10, transcript variant X2
myosin heavy chain 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X1
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X9
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X2
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X6
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X7
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X8
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X5
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X3
phosphoinositide-3-kinase regulatory subunit 5, transcript variant X4
phosphoinositide 3-kinase regulatory subunit 5 isoform X1
phosphoinositide 3-kinase regulatory subunit 5 isoform X2
phosphoinositide-3-kinase regulatory subunit 6, transcript variant X4
phosphoinositide-3-kinase regulatory subunit 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
phosphoinositide-3-kinase regulatory subunit 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
phosphoinositide-3-kinase regulatory subunit 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
phosphoinositide 3-kinase regulatory subunit 6
major facilitator superfamily domain containing 6 like
major facilitator superfamily domain-containing protein 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 10% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 42
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin carboxyl-terminal hydrolase 43
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cytochrome P450 2C5-like, transcript variant X1
cytochrome P450 2C5-like, transcript variant X2
F-box/WD repeat-containing protein 10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
trans-golgi network vesicle protein 23 homolog C
Golgi apparatus membrane protein TVP23 homolog C
heparan sulfate-glucosamine 3-sulfotransferase 3B1
heparan sulfate glucosamine 3-O-sulfotransferase 3B1
protoheme IX farnesyltransferase, mitochondrial
uncharacterized LOC125335970, transcript variant X2
uncharacterized LOC125335970, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC125335817, transcript variant X1
uncharacterized LOC125335817, transcript variant X2